| 1 |
Randomized, controlled trial of rasagiline as an add‐on to dopamine agonists in Parkinson's disease
Robert A. Hauser, Dee E. Silver, Azhar Choudhry et al. · Movement Disorders
|
11 Jun 2014 |
56 |
| 2 |
Prior suggestive symptoms in one-third of patients consulting for a "first" demyelinating event
Olivier Gout, Christine Lebrun‐Frénay, Pierre Labauge et al. · Journal of Neurology Neurosurgery & Psychiatry
|
19 Nov 2010 |
44 |
| 3 |
Improved asthma control with breath-actuated pressurized metered dose inhaler (pMDI): the SYSTER survey.
Violaine Giraud, François‐André Allaert · PubMed
|
5 Jan 2010 |
32 |
| 4 |
Pharmacokinetics of Quinupristin/ Dalfopristin in Patients with Severe Chronic Renal Insufficiency
Paul Chevalier, Jacques Rey, Oliver Pasquier et al. · Clinical Pharmacokinetics
|
Jul 2000 |
15 |
| 5 |
Update on hydrocodone metabolites in rats and dogs aided with a semi-automatic software for metabolite identification Mass-MetaSite
Austin C. Li, James P. Chovan, Erya Yu et al. · Xenobiotica
|
30 Aug 2012 |
13 |
| 6 |
Pan‐ E uropean, open‐label dose titration study of fentanyl buccal tablet in patients with breakthrough cancer pain
Ulrich Richard Kleeberg, Andrew Neil Davies, Joanna Jarosz et al. · European Journal of Pain
Open access |
2 Sep 2014 |
10 |
| 7 |
Evaluation of the Potential for a Pharmacokinetic Drug–Drug Interaction Between Armodafinil and Ziprasidone in Healthy Adults
Mona Darwish, Mary Lou Bond, Ronghua Yang et al. · Clinical Drug Investigation
|
21 Jul 2014 |
5 |
| 8 |
Clinical practice guidelines for the treatment of tardive dyskinesia in Europe: A descriptive review
Mark John Edwards, Pierre‐Michel Llorca, Maurice T. Driessen et al. · European Psychiatry
Open access |
2025 |
3 |
| 9 |
Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users
Mary Lou Bond, Kerri A. Schoedel, Laura Rabinovich‐Guilatt et al. · Pain Medicine
Open access |
17 May 2017 |
1 |
| 10 |
[Rating criteria for selection of an inhaler and instructing its use in patients with asthma and COPD].
Rafał Ludwikowski, Tadeusz Płusa, Paweł Bijoś · PubMed
|
22 Dec 2016 |
1 |
| 11 |
Medicinal Chemistry Perspectives on PFAS in Drug Design: Fluorinated Motifs, Innovation, and Patient Impact
Leena Otsomaa, Michelle R. Garnsey, Harrie J. M. Gijsen et al. · Journal of Medicinal Chemistry
Open access |
28 Jul 2026 |
0 |
| 12 |
Real-World Specialty-Based Differences in the Diagnosis and Management of Tardive Dyskinesia: Results of a Physician Survey From Italy, Spain, France, and the United Kingdom
A. Fagiolini, M. T. Driessen, A. Guevara Morel et al. · European Psychiatry
Open access |
Jun 2026 |
0 |
| 13 |
Patient Experience With Once-daily Deutetrabenazine Extended-release Tablets for the Treatment of Tardive Dyskinesia in Individuals With Prior Valbenazine Use (P7-16.003)
Rakesh Jain, Martijn Konings, MSc Maurice Driessen et al. · Neurology
|
9 Jun 2026 |
0 |
| 14 |
87 Phenotypic variability of Circulating Natural Killer Cells in healthy donors
Léa Siksou, Gaurav Kumar, Weimin Kong et al. · Clinical Immunology
|
23 Apr 2024 |
0 |
| 15 |
Chorea Severity Change Over Time in Huntington Disease and by Huntington Disease Stage (P1-11.010)
Erin E. Furr-Stimming, Victor Sung, Shoshana Reshef et al. · Neurology
|
25 Apr 2023 |
0 |
| 16 |
Comparative Effect of Atorvastatin and Rosuvastatin in cardiovascular Diseased patients
Sravan Kumar, R Yashaswini, Prashanthi Gundlapally et al. · Acta Scientific Pharmaceutical Sciences
Open access |
18 Feb 2022 |
0 |
| 17 |
Efficacy and Safety of Lipegfilgrastim for the Prophylaxis of Chemotherapy-induced Neutropenia in Breast Cancer Patients in Poland
Joanna Streb, Jakub Kucharz, Aurelia Lipa et al. · Archives of Medical Science
Open access |
12 Aug 2021 |
0 |